Despite challenges, ultrasound remains useful in obese trauma patients. Using the lowest frequency ultrasound probe along with tissue harmonic imaging improves image quality, according to an education exhibit presented at RSNA 2009.
Despite challenges, ultrasound remains useful in obese trauma patients. Using the lowest frequency ultrasound probe along with tissue harmonic imaging improves image quality, according to an education exhibit presented at RSNA 2009.
"Ultrasound is often worthwhile attempting, despite individual variations in the distribution and sound attenuation of fat," said lead author Dr. Michael Modica, a radiologist at the University of Washington in Seattle. "The ultrasound machine should be set to ‘penetrate' mode. Position the patient to move the fat away from the sound beam. The aorta and kidney can be scanned with a coronal or posterior oblique approach in some obese patients."
In ultrasound, both the thickness of subcutaneous fat and the sound-attenuating properties of fat present difficulties. Sound attenuation increases exponentially with fat thickness, Modica said. Furthermore, ultrasound attenuation is frequency-dependent; the greater the frequency, the higher the sound attenuation, he said. For instance, a sound wave emitted from a 7-MHz transducer is attenuated by 50% after travelling through 1 cm of fat. When imaging an obese patient with 8 cm of subcutaneous fat, 94% of the original sound wave is attenuated before it reaches the peritoneal cavity.
Lowering the frequency of the transducer decreases attenuation, allowing more of the primary beam to penetrate the subcutaneous fat and reach peritoneal organs and deep vascular structures. When tissue harmonic imaging is used, harmonic beams are produced beyond the body wall, which reduces the defocusing effect of the body wall, produces better penetration in obese patients, and improves lesion detection, Modica said.
For radiography, he recommends using smart collimation and antiscatter grids and tightly coning the region of interest.
In CT, position the patient so the region of interest is in the separation of variables (SOV). Bundle the patient to increase his or her ‘roundness,' and if possible, use a wider, extrapolated reconstruction field-of-view and algorithms for truncation artifact reduction-and consider iterative reconstruction, Modica said. To avoid severe photon starvation, consider the generator and tube capacity in all future CT purchases, and optimize CT protocols for obese patients by increasing kVp , mAs, and slice thickness, and reduce pitch to improve the signal-to-noise ratio, Modica advised. As well as using specific protocols for children and small patients, design specific scanning protocols for obese patients.
Improvements in image quality often come by compromising on radiation dose, particularly in the obese patient, and preliminary studies imply significant increase in CT dose when comparing thin, overweight, and obese patients, he said.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Techsomed Launches Ultrasound-Based Software Suite for Liver Tumor Ablation Therapy
July 29th 2024Featuring the previously FDA-cleared BioTraceIO Vision and BioTraceIO Precision modalities, the BioTrace software suite combines real-time ultrasound guidance and advanced AI technology to help bolster outcomes with liver tumor ablation therapy.